Skip to content
value.today

AnGes, Inc.: peers

Change the peers

AnGes, Inc. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

AnGes, Inc., RaQualia Pharma Inc., StemRIM Inc., ReproCELL Incorporated, Japan Tissue Engineering Co., Ltd., Stella Pharma Corporation, CanBas Co., Ltd., Immuno-Biological Laboratories Co., Ltd.: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

AnGes, Inc., RaQualia Pharma Inc., StemRIM Inc., ReproCELL Incorporated, Japan Tissue Engineering Co., Ltd., Stella Pharma Corporation, CanBas Co., Ltd., Immuno-Biological Laboratories Co., Ltd. side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureAnGes, Inc.base
4563.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
RaQualia Pharma Inc.
4579.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
StemRIM Inc.
4599.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
ReproCELL Incorporated
4978.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
Japan Tissue Engineering Co., Ltd.
7774.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
Stella Pharma Corporation
4888.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
CanBas Co., Ltd.
4575.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
Immuno-Biological Laboratories Co., Ltd.
4570.T · 🇯🇵 JP
Percentile in Healthcare
Percentile in Japan
Group median
Size
Market cap (Better neither way: ranked highest first)$142 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one3rd of 8$148 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one2nd of 8$119 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one4th of 8$115 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one5th of 8$186 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one1st of 8$101 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one6th of 8$100 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one7th of 8$89 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one8th of 8$117 M8 ranked

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = AnGes, Inc.: How market caps are worked out; RaQualia Pharma Inc.: How market caps are worked out; StemRIM Inc.: How market caps are worked out; ReproCELL Incorporated: How market caps are worked out; Japan Tissue Engineering Co., Ltd.: How market caps are worked out; Stella Pharma Corporation: How market caps are worked out; CanBas Co., Ltd.: How market caps are worked out; Immuno-Biological Laboratories Co., Ltd.: How market caps are worked out.

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

Fewer than two years of revenue are on file for these companies.

Rank in the group

Ranks need two fiscal years with the figure for at least two of these companies.

Suggested peers of AnGes, Inc.#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • RaQualia Pharma Inc.4579.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $148 M market cap against $142 M · Same country: Japan
    Market cap $148 M (last known, Mar 8, 2026)
    95 of 100 (industry or sector 50 + size 30 + country 15)
    In the group
  • StemRIM Inc.4599.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $119 M market cap against $142 M · Same country: Japan
    Market cap $119 M (last known, Mar 8, 2026) · revenue $19 M (year to July 2020)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • ReproCELL Incorporated4978.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $115 M market cap against $142 M · Same country: Japan
    Market cap $115 M (last known, Mar 8, 2026)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Japan Tissue Engineering Co., Ltd.7774.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $186 M market cap against $142 M · Same country: Japan
    Market cap $186 M (last known, Mar 8, 2026) · revenue $21 M (year to March 2021)
    93 of 100 (industry or sector 50 + size 28 + country 15)
    In the group
  • Stella Pharma Corporation4888.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $101 M market cap against $142 M · Same country: Japan
    Market cap $101 M (last known, Mar 8, 2026)
    93 of 100 (industry or sector 50 + size 28 + country 15)
    In the group
  • CanBas Co., Ltd.4575.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $100 M market cap against $142 M · Same country: Japan
    Market cap $100 M (last known, Mar 8, 2026)
    93 of 100 (industry or sector 50 + size 28 + country 15)
    In the group
  • Immuno-Biological Laboratories Co., Ltd.4570.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $89 M market cap against $142 M · Same country: Japan
    Market cap $89 M (last known, Mar 8, 2026)
    92 of 100 (industry or sector 50 + size 27 + country 15)
    In the group
  • Kubota Pharmaceutical Holdings Co., Ltd.4596.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $88 M market cap against $142 M · Same country: Japan
    Market cap $88 M (last known, Mar 8, 2026)
    92 of 100 (industry or sector 50 + size 27 + country 15)
    + Add
  • Gene Techno Science4584.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $86 M market cap against $142 M · Same country: Japan
    Market cap $86 M (last known, Mar 8, 2026)
    92 of 100 (industry or sector 50 + size 27 + country 15)
    + Add
  • Jyong Biotech Ltd.MENS · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $154 M market cap against $142 M · Same region: Eastern Asia · Ratios of the last two fiscal years on file
    Market cap $154 M (Aug 1, 2026)
    92 of 100 (industry or sector 50 + size 30 + country 7 + figures on file 5)
    + Add
  • Nanocarrier4571.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $82 M market cap against $142 M · Same country: Japan
    Market cap $82 M (last known, Mar 8, 2026)
    91 of 100 (industry or sector 50 + size 26 + country 15)
    + Add
  • CellSeed Inc.7776.T · 🇯🇵 Japan
    Same industry: Biotechnology · Similar size: $77 M market cap against $142 M · Same country: Japan
    Market cap $77 M (last known, Mar 8, 2026)
    91 of 100 (industry or sector 50 + size 26 + country 15)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.